CombiMatrix and Strand Genomics Enter into Co-Marketing Agreement.NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG ACTG Acting ACTG AIDS Clinical Trial Group ACTG Actuating/Actuator ) announced today that its CombiMatrix group has entered into a co-marketing agreement with Strand Genomics to market its product avadis, a data analysis software tool for microarray gene expression. "Strand Genomics is rapidly becoming a recognized provider of quality commercial software serving the microarray analysis marketplace," said Dr. Amit Kumar, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CombiMatrix. "We look forward to offering our growing customer base products designed to make it easier to order, manage, analyze and interpret their CustomArray(TM) microarray data." "We are excited to partner with CombiMatrix and believe their new revolutionary CustomArray(TM) products will bring tremendous advantages to researchers in the molecular lifescience marketplace," said Vijay Chandru, Ph.D., CEO of Strand Genomics. avadis is a data analysis and visualization tool that combines scalable analytical algorithms with powerful and interactive visualization Interactive visualization is a branch of graphic visualization in computer science that studies how humans interact with computers to create graphic illustrations of information and how this process can be made more efficient. to derive valuable insights from gene expression data. avadis enables CombiMatrix's customers to seamlessly order, redesign, and reorder re·or·der v. re·or·dered, re·or·der·ing, re·or·ders v.tr. 1. To order (the same goods) again. 2. To straighten out or put in order again. 3. To rearrange. v. CustomArrays through various data analysis approaches within the avadis software. It also provides a wide range of clustering techniques and statistical tests that make up the complete analysis toolset. avadis is a comprehensive solution that meets all the needs of gene expression researchers with a superior performance-to-price feature. ABOUT CUSTOMARRAY(TM) CustomArrays(TM) are semiconductor-based microarrays in a standard 1" x 3" slide format. CustomArray enables total customization of content with complete flexibility allowing the researcher to study any genome, any gene or any species in any quantity desired. CombiMatrix synthesizes oligonucleotides in situ In place. When something is "in situ," it is in its original location. to build unique CustomArrays. This revolutionary technology allows CombiMatrix to deliver CustomArrays in days. Sensitivity and performance metrics are available on the company's main web site and at www.customarray.com. Researchers can place orders for CustomArray products by contacting CombiMatrix at (800) 985-2269 or by accessing CombiMatrix's order site at www.customarray.com. ABOUT STRAND GENOMICS PVT LTD LTD 1 Laron-type dwarfism 2 Leukotriene D 3 Long-term depression, see there 4. Long-term disability Strand is a global life sciences informatics company focused on software for drug discovery and development. Strand has leveraged its core strengths in data mining and predictive modeling to develop its products avadis and truPK. avadis is a comprehensive microarray data analysis and visualization software. truPK is an in-silico ADME ADME Absorption, Distribution, Metabolism, and Excretion ADME Association of Destination Management Executives ADME Active Duty Medical Extension (PharmacoKinetic) predictive modeling technology developed by Strand. Strand offers the truPK models for licensing and consulting services for custom model building. Strand is based in Bangalore, India, with a marketing and corporate development office in California. For more information on Strand, visit the company's website at http://www.strandgenomics.com, for more information on avadis visit http://avadis.strandgenomics.com and for more information on truPK visit http://trupk.strandgenomics.com. ABOUT ACACIA RESEARCH CORPORATION Acacia Research Corporation comprises two operating groups: Acacia Technologies Group and CombiMatrix Group. The CombiMatrix group is developing a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix's technology has a wide range of applications including DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. synthesis/diagnostics, siRNA synthesis, drug discovery, and immunochemical im·mu·no·chem·is·try n. The chemistry of immunologic phenomena, as of antigen-antibody reactions. im detection. CombiMatrix provides DNA arrays to researchers under the CustomArray(TM) brand. CombiMatrix's Express Track(sm) drug discovery program is a systems biology approach, using its technology, to target common viral diseases with siRNA compounds. The Acacia Technologies Group develops, acquires, and licenses patented technologies. Acacia's DMT See DSL. technology, which is supported by 5 U.S. and 31 foreign patents, relates to audio and audio/video transmission and receiving systems commonly known as audio-on-demand, video-on-demand, and audio/video streaming, and is used for distributing digital content via several means including Internet, cable, satellite and wireless systems. Acacia Research-Acacia Technologies (Nasdaq:ACTG) and Acacia Research-CombiMatrix (Nasdaq:CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups. Information about the Acacia Technologies Group and the CombiMatrix Group is available at www.acaciaresearch.com. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. , recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion